Gujarat Fluorochemicals Ltd Q1 FY27 Earnings Call Summary

Event Participants

Executives

4
Bir Kapoor (CEO & Deputy Managing Director), Kapil Malhotra (Business Head - Fluoropolymers), Manoj Agrawal (CFO), Rajiv Rao (Business Head - Battery Materials)

Analysts

9
Ankur Periwal (Axis Capital), Arun Prasath (Avendus Spark), Dhruv Muchhal (HDFC AMC), Meet Vora (JM Financial), Naushad Chaudhary (Aditya Birla Sun Life MF), Omkar Chachad (Motilal Oswal), Preet Jain (Niveshaay Investment), Rohit Nagraj (360 ONE Capital), Sanjesh Jain (ICICI Securities)

Financials & KPIs

Geographic & Segment Commentary

• Fluoropolymers: Revenue grew 15% YoY and 8% QoQ, driven by value-added product mix shift toward higher grades and new-age applications (semiconductors, data centers, electronics, automotive, green hydrogen). New fluoropolymer capacity nearing full utilization; debottlenecking is a continuous process. 3M's exit impact fully absorbed over last two years; AGC's announced UK facility shutdown generating new customer inquiries and qualification work expected to convert in 1-2 quarters.

• Fluorochemicals: Exceptionally strong quarter with revenue +52% YoY and +44% QoQ, led by R32 refrigerant sales. Existing R32 capacity is at peak utilization; expansion commissioning in Q2 FY27. R134a project on schedule for FY27 commissioning, completing a product bouquet (R32, R134a, R125) that enables blended R410a sales. AHF capacity additions planned in phases from Q3 FY27 to support refrigerant growth.

• Bulk Chemicals: Steady performance with revenue +11% YoY and +1% QoQ, primarily driven by improved realizations.

• Battery Materials: LiPF6 qualification with global electrolyte manufacturers is nearly complete and moving into growth phase; PVDF binders close to finalizing qualification; LFP cathode active material targeted for commercialization toward end FY27. Electrolyte qualification with Indian cell manufacturers progressing with customer audits. Revenue growth expected to be significant quarter-by-quarter, with three-digit quarterly revenue guided for Q4 FY27.

Company-Specific & Strategic Commentary

• Refrigerant Portfolio Expansion: R32 capacity expansion (from ~10,000 to 20,000 tons) commissioning in Q2 FY27; R134a brownfield expansion on track for FY27. Combined with 125, this creates a unique position to supply R410a blends globally. Quota entitlement strategy based on GWP baseline formula, with production quota calculated per past precedents. Sales mix ~40-50% long-term contracts, balance spot; pricing for domestic and export markets very close.

• Battery Materials India Relocation: Oman project placed on hold due to geopolitical delays; capacities being relocated to India (Jolva plant and a new Dahej site) to accelerate commercialization and meet customer commitments. The sovereign fund (OIA) funding of ~₹1,200 crore tied to Oman is no longer available; management will raise alternate funding but sees no constraint. Domestic battery demand projection of 220-250 GWh by 2030 (BESS-driven) strengthens the India case.

• Fluoropolymer High-Value Migration: Growth (15-20% annually) driven predominantly by product mix improvement and value-added grades rather than price increases; formula-based contracts protect margins from raw material volatility (sulfur up 3-4x, fluorspar). Capex in new fluoropolymers (PFA, FKM, PVDF) aligned with semicon, green hydrogen, and data center demand; most customer approvals expected in place by end FY27, enabling faster ramp of new capacity.

• Capex & Capitalization: FY27 spending plan of ₹2,300 crore (EV) + ₹800 crore (chemicals) holding; gross block at ₹836 crore, with ~₹1,200 crore of existing CWIP targeted for capitalization by year-end — a trigger-based process dependent on plant start-up and product quality stabilization.

Guidance & Outlook

Risks & Constraints

Q&A Highlights

Fluoropolymer Pricing and Growth Drivers

• Question: Have GFL taken price increases following Chinese peer hikes, and what is the blended price impact? (Sanjesh Jain, ICICI Securities)
• Answer: GFL avoids direct competition with Chinese peers by moving up the value chain into higher-grade products; small margin-correction price increases were taken to offset input cost inflation, which will reflect in subsequent quarters. Growth is driven by value (mix improvement) rather than price. (Kapil Malhotra)

New Fluoropolymer Capacity

• Question: Where are the growth opportunities and what capacities are planned? (Sanjesh Jain)
• Answer: New fluoropolymer capacity is nearly fully utilized; additions will focus on high-end products catering to semicon, data centers, and green hydrogen, though specific product/capacity details remain confidential. Management reaffirmed the 17-20% growth trajectory as "absolutely visible." (Bir Kapoor)

Battery Materials Revenue Ramp

• Question: When will battery chemicals revenue step up meaningfully given current small revenue base? (Sanjesh Jain)
• Answer: LiPF6 is first to ramp (qualification nearly done), followed by PVDF (close to finalizing) and LFP cathode (by end FY27). Three-digit quarterly revenue targeted by Q4 FY27 with significant scale-up in FY28. Some Q1 dispatches were on CIF terms and will reflect in Q2 revenue. Incremental ₹2,300 crore capex ramp will be faster since qualification cycles are largely complete. (Bir Kapoor)

R134a Entry Rationale

• Question: Why enter 134a so late in the HFC journey, and what about quota allocation? (Arun Prasath, Avendus Spark)
• Answer: R134a represents a strong market opportunity with restricted future supply, robust demand, and HFO alternatives at significantly higher price points. Capacity will be ready by end FY27; some strategic reasons cannot be shared. The capacity will enable use of GFL's full entitlement quota across R32, R134a, and R125. (Bir Kapoor)

Standalone vs Consolidated Gap

• Question: Why is the gap between standalone and consolidated results widening beyond EV contributions? (Arun Prasath)
• Answer: The gap reflects GFL EV, GFL USA LLC, and GFL GmbH — the latter handles polymer business routed through Germany/US subsidiaries, which doesn't appear in standalone. Q1 saw some CIF consignments and goods-in-transit previously booked in subsidiaries reversed into standalone, widening the gap. (Manoj Agrawal)

AHF Backward Integration

• Question: Are additional HF/AHF capacities planned for R32 expansion? (Preet Jain, Niveshaay)
• Answer: Yes, AHF capacities will be added in phases starting Q3 FY27, matched to refrigerant capacity additions; used for internal consumption only at this point. (Bir Kapoor)

Quota Allocation for New Players

• Question: Will new entrants get R32 production quota or only incumbents? (Preet Jain)
• Answer: Management cannot comment on regulator decisions; past precedents indicate baseline-based allocation with a GWP-based formula. GFL's expansion plans are sized to its own entitlement understanding based on prior patterns. (Bir Kapoor)

Capex Capitalization Timing

• Question: Of the ₹1,900 crore CWIP, how much capitalizes in FY27? (Omkar Chachad, Motilal Oswal)
• Answer: ~₹1,200 crore expected to capitalize by end FY27, contingent on plant start-up and product quality stabilization triggers. FY27 spending (₹2,300 crore EV + ₹800 crore chemicals) adds to CWIP before later capitalization. (Bir Kapoor, Manoj Agrawal)

Oman Project on Hold

• Question: What is the status of the Oman battery materials project and associated funding? (Unidentified; Naushad Chaudhary, Aditya Birla MF)
• Answer: Oman project is on hold due to geopolitical delays; capacities are being relocated to India (Jolva and a new Dahej site) for speed. The ~₹1,200 crore OIA sovereign fund approved specifically for Oman is not available for India; alternate fundraising is underway with no perceived constraint. Land, approvals, and infrastructure at existing sites are sufficient for first phase; additional Dahej site coming for FY28 expansions. (Bir Kapoor)

Fluoropolymer Contract Pricing

• Question: How are contracts structured given the 3-4x sulfur price increase? (Meet Vora, JM Financial)
• Answer: Formula-based pricing agreements with key customers protect margins; cost increases were managed through these formulas. Q1 results demonstrate margin protection despite raw material volatility. (Kapil Malhotra)

R32 Utilization and Sales Mix

• Question: What was R32 utilization, and is the revenue split domestic vs export, spot vs contract? (Dhruv Muchhal, HDFC AMC; Arun Prasath)
• Answer: R32 capacity is almost fully utilized. Sales target the global market given GFL's three-decade legacy in international refrigerant marketing; ~40-50% long-term contracts, the balance spot/contract. Domestic and export pricing are very close. R32 is also sold as R410a blends, leveraging GFL's unique position of having both R125 and R32. (Bir Kapoor)

3M/AGC Market Share Impact

• Question: Is GFL capturing 3M's vacated market, and will AGC's UK closure add demand? (Rohit Nagraj, 360 ONE Capital)
• Answer: 3M's exit impact has been fully absorbed over the past two years, contributing to current high-value growth. AGC's announcement is recent; customer inquiries are coming in and qualification has started, with traction expected in 1-2 quarters. GFL has matching grades available for AGC's product line. (Kapil Malhotra)

Key Takeaway

GFL delivered a strong Q1 FY27 with consolidated revenue up 24% YoY to ₹1,588 crore, EBITDA up 24% to ₹428 crore, and PAT up 19% to ₹219 crore. Fluorochemicals (R32-led) grew 52% YoY and fluoropolymers 15% YoY, with consolidated EBITDA margin expanding 500 bps QoQ to 27%, ROCE up 258 bps to 16.6%, and working capital days down 43 to 149. Management reaffirmed 17-20% fluoropolymer growth and guided battery materials to three-digit quarterly revenue by Q4 FY27 with significant FY28 scale-up, while R32 expansion (Q2 FY27) and R134a (FY27) complete the refrigerant bouquet and AHF additions proceed in phases. The ₹6,000-crore two-year capex plan holds with ~₹1,200 crore CWIP capitalization expected in FY27; the Oman project is on hold with capacities relocating to India. Watch points include raw material volatility (sulfur, fluorspar), refrigerant quota allocation uncertainty, and battery qualification timelines as the company positions for sustained chemical segment growth through FY28.